We are live on ! Find out more
BE

Bonness Enterprises Portfolio holdings

AUM $310M
1-Year Est. Return 24.22%
This Fund
S&P 500
This Quarter Est. Return
+4.92%
1 Year Est. Return
+24.22%
3 Year Est. Return
+94.56%
5 Year Est. Return
+137.52%
10 Year Est. Return
+441.57%
AUM
$187M
AUM Growth
+$8.17M
Cap. Flow
+$1.75M
Cap. Flow %
0.94%
Top 10 Hldgs %
64.27%
Holding
39
New
Increased
4
Reduced
Closed

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$1.71M
2
GSK icon
GSK
GSK
+$21.8K
3
T icon
AT&T
T
+$17.6K
4
VZ icon
Verizon
VZ
+$5.64K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Financials 32.39%
2 Healthcare 28.74%
3 Technology 24.33%
4 Industrials 4.18%
5 Consumer Staples 4.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PGR icon
1
Progressive
PGR
$122B
$54.7M 29.28%
572,608
SYK icon
2
Stryker
SYK
$130B
$16.7M 8.91%
68,400
MSFT icon
3
Microsoft
MSFT
$3.64T
$10.9M 5.85%
46,400
AAPL icon
4
Apple
AAPL
$4.49T
$6.71M 3.59%
54,940
JNJ icon
5
Johnson & Johnson
JNJ
$611B
$6.4M 3.42%
38,938
INTC icon
6
Intel
INTC
$458B
$5.69M 3.04%
88,950
MRK icon
7
Merck
MRK
$315B
$5.36M 2.87%
72,836
+23,161
+47% +$1.71M
TMO icon
8
Thermo Fisher Scientific
TMO
$214B
$5.2M 2.78%
11,400
CSCO icon
9
Cisco
CSCO
$457B
$4.29M 2.29%
82,900
AMAT icon
10
Applied Materials
AMAT
$409B
$4.18M 2.24%
31,300
ABBV icon
11
AbbVie
ABBV
$435B
$3.96M 2.12%
36,600
IBM icon
12
IBM
IBM
$215B
$3.93M 2.1%
30,819
EMR icon
13
Emerson Electric
EMR
$85.9B
$3.92M 2.1%
43,500
ABT icon
14
Abbott
ABT
$185B
$3.92M 2.1%
32,700
UL icon
15
Unilever
UL
$138B
$3.9M 2.09%
62,169
NUE icon
16
Nucor
NUE
$59B
$3.8M 2.03%
47,350
BMY icon
17
Bristol-Myers Squibb
BMY
$133B
$3.35M 1.79%
53,100
MRSH
18
Marsh
MRSH
$92B
$3.14M 1.68%
25,800
PFE icon
19
Pfizer
PFE
$142B
$2.85M 1.52%
78,608
WLY icon
20
John Wiley & Sons Class A
WLY
$2.68B
$2.62M 1.4%
48,400
PHG icon
21
Philips
PHG
$25.5B
$2.58M 1.38%
55,880
UPS icon
22
United Parcel Service
UPS
$90.7B
$2.54M 1.36%
14,950
GLW icon
23
Corning
GLW
$127B
$2.45M 1.31%
56,400
A icon
24
Agilent Technologies
A
$39.4B
$2.28M 1.22%
17,900
PG icon
25
Procter & Gamble
PG
$337B
$2.22M 1.19%
16,400

Similar funds

Bonness Enterprises's Q1 2021 Portfolio in Review

As of Q1 2021, Bonness Enterprises held 39 positions worth $187M, up 4.6% from $179M the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Trading was light in Q1 2021: portfolio turnover was 0%. Bonness Enterprises opened no new positions and made no exits, leaving the 39-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 32% of assets, down from 35% a quarter earlier, followed by Healthcare and Technology.

  • Bonness Enterprises added most to Merck in Q1 2021, an estimated $1.71M increase.
  • Bonness Enterprises's ten largest holdings make up 64% of its $187M portfolio in Q1 2021.
  • Bonness Enterprises opened 0 new positions and closed 0 in Q1 2021.
  • Bonness Enterprises's portfolio value rose 4.6% quarter-over-quarter to $187M.

Based on Bonness Enterprises's 13F filing for Q1 2021, filed 9 Apr 2021.